This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Heroin Addiction or Substance Use Disorders
and you are
over 20
years old
The phase for this study is not defined.
Show me locations

The purpose

This study aims to study and implement active referral of heroin users from a syringe exchange programme to evidence-based treatment for heroin addiction. Patients are randomized to either a strength-based case management intervention or a control group, while both groups receive referral to medical investigation for inclusion in substitution treatment for heroin addiction. The hypothesis is that syringe exchange can be used for referral to effective treatment, and that a strength-based intervention can increase the number of patients who are successfully referred and enter treatment.

Provided treatments

  • Behavioral: Strength-based case management
  • Behavioral: Control condition - referral only

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01457872. The sponsor of the trial is Region Skane and it is looking for 79 volunteers for the current phase.
Official trial title:
Malmö Treatment Referral and Intervention Study